US FDA approves Abilify for irritability in autistic children
This article was originally published in Scrip
Executive Summary
The US FDA has approved Otsuka Pharmaceutical/Bristol-Myers Squibb's Abilify (aripiprazole) for the treatment of irritability in patients aged six to 17 years with autism.